STAT
JUNE 19, 2024
LAS VEGAS — Downstairs was a sensory overload: Roulette wheels spun, slot-machine chimes rang, and dealers hurried to scoop up stacks of casino chips resting in front of busted blackjack hands. Many gamblers held a drink in one hand and a cigarette in the other. It was perhaps a strange setting for a conference about substance use treatment.
pharmaphorum
JUNE 19, 2024
An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 19, 2024
Priscilla Agnew-Hines will never be able to forget that day in early 2020. On March 26, just weeks after Covid-19 officially became a global pandemic, her son died from an overdose. Larry, 41, was a chef, a drummer for his gospel church and the son who challenged Priscilla’s barbecue skills during summer cookouts. He also struggled with addiction.
Pharmafile
JUNE 19, 2024
Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s next-generation capsid assembly modulator (CAM) candidate currently being developed for the treatment of chronic hepatitis B virus (HBV) infection. The post First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment appeared first on Pharmafile.
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
STAT
JUNE 19, 2024
Millions of people around the world are living with long Covid, a medically perplexing, and potentially debilitating, condition. Rachel Hall-Clifford is one of them. As a medical anthropologist, she’s well suited to understanding long Covid. But as a mother, wife, friend, researcher, and teacher, it drags her down, just as it does so many others.
Express Pharma
JUNE 19, 2024
A substantial 63 per cent of life sciences companies, including those in biopharma, currently have connected health products on the market or in development. Regardless of their product development stage, these organisations predict that connected health will generate over 20 per cent of their revenue within five years. Yet a lack of essential data capabilities could hamper this ambition.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
JUNE 19, 2024
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs.
STAT
JUNE 19, 2024
Just two weeks ago, it appeared Novant Health was on the precipice of finalizing a deal to acquire two hospitals north of Charlotte, even though federal antitrust regulators, North Carolina officials, and economists were worried the deal would give Novant near-monopoly power in the region. But Novant, a nonprofit hospital system with $8 billion of revenue, decided to call off the deal mere hours after a federal court of appeals temporarily prevented Novant from buying the hospitals until the Fed
Express Pharma
JUNE 19, 2024
AstraZeneca announced that its breast cancer drug, Truqap, in combination with chemotherapy agent, paclitaxel, did not meet its main goals in a late-stage trial to improve overall survival of patients with a type of breast cancer on June 18, 2024. The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients with inoperable or metastatic triple-negative breast cancer versus the older and cheaper chemotherapy agent, paclitaxel, in combination wi
pharmaphorum
JUNE 19, 2024
Improving maternity care is crucial, and healthtech innovations can play a significant role in enhancing maternal health outcomes. Explore how technology can revolutionise maternal care.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
JUNE 19, 2024
Syngene International, an integrated research, development and manufacturing services company, announced the second cohort of the scholarship, mentoring and industry orientation for women in STEM (science, technology, engineering, and mathematics) in collaboration with the Research and Innovation Circle of Hyderabad (RICH). This program offers scholarships to women studying STEM subjects at tier two and three institutions across various regions of the country to enable them to gain industry exp
The Pharmacist
JUNE 19, 2024
Pharmacies can be paid for a Pharmacy First consultation for any minor illness that is referred from a GP surgery, even if this is not covered by the seven common conditions listed in the service specification, Community Pharmacy England (CPE) has clarified. And they warned that rejecting GP referrals inappropriately ‘may affect the GP practice […] The post Claim Pharmacy First for any minor ailment GP referral, says CPE appeared first on The Pharmacist.
European Pharmaceutical Review
JUNE 19, 2024
A non-chemotherapy multi-drug therapy enabled complete remission in 38 percent of evaluable patients with aggressive B-cell lymphoma, a Phase Ib/II clinical trial shows. This was observed in individuals who had experienced a return of their cancer or who were unresponsive to standard treatments. Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) were used together in a treatment regimen in 50 patients with diffuse large B-cell lymphoma (DLBCL).
pharmaphorum
JUNE 19, 2024
Discover the importance of data in the process of commercialising drugs for rare diseases and how it plays a critical role in advancing treatment options for patients. Learn more about orphan diseases and drug development.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
JUNE 19, 2024
Beacon Therapeutics initiated the final leg of the race for its lead asset, AGTC-501 (laruparetigene zovaparvovec), announcing recently that the company has treated its first patient in the pivotal trial, VISTA. Currently, the only retinitis pigmentosa therapy on the market is Spark Therapeutics’ Luxturna (voretigene neparvovec), a retinoid isomerohydrolase activator, indicated for patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy.
Pharma Times
JUNE 19, 2024
The serious condition is responsible for approximately 11 million deaths worldwide every year
Express Pharma
JUNE 19, 2024
Avendus Capital, recently released a report that navigates the shifting tides in the Indian Domestic Formulations (DomForm) market, estimating that it will cross INR 5.5 trillion by 2034 at a CAGR of 10 per cent. The report foresees some fundamental model shifts, such as a gradual transition from a primarily doctor branded prescription model to an alternative marketing and channel mix, aided by more stringent quality compliance, which would lead to a rationalisation of supply chains.
pharmaphorum
JUNE 19, 2024
Marea Therapeutics raises $190m for cardiometabolic pipeline, with Santa Ana Bio, Opthea, InduPro, Elion, and iOnctura also completing rounds
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
JUNE 19, 2024
Orchid Pharma, a Chennai-based pharmaceutical company catering across the pharmaceutical value chain (discovery to delivery) with expertise in R&D and marketing, has announced the appointment of Chief Executive Officer (CEO), Rajnish Rohatgi. He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives, to favourably impact a key aspect of Indian public health.
Pharma Times
JUNE 19, 2024
Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children
The Pharmacist
JUNE 19, 2024
Public health officials have warned that cases of dengue fever in Europe are continuing to rise as climate change creates favourable conditions for invasive mosquitoes. Figures show that last year there were 130 cases of dengue acquired in a European country compared with 71 in 2022. Between 2020 and 2021 there were only 73 locally […] The post Warnings of rising cases of dengue fever in European countries appeared first on The Pharmacist.
Express Pharma
JUNE 19, 2024
MSD has announced the launch of its IDEA Studios, a new initiative led by the MSD Global Health Innovation Fund and MSD’s regional teams to fund and collaborate with entrepreneurs and early-stage companies focused on delivering transformative health care solutions. Announced at the HLTH Europe conference, MSD IDEA Studio Asia Pacific and MSD IDEA Studio Europe will combine the company’s industry-leading corporate venture arm with the health care expertise of its regional business teams.
Outsourcing Pharma
JUNE 19, 2024
During a panel discussion held at DIA Global in San Diego this week, which was moderated by Peter Wahl, industry experts delved into the integration of real-world (RW) data and advanced technologies to accelerate drug development.
pharmaphorum
JUNE 19, 2024
Sobi’s long-acting rVIII drug Altuvoct has been cleared for haemophilia A in the EU, with a label that spans all ages and any disease severity.
Pharmaceutical Commerce
JUNE 19, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses what to expect from Cardinal Health's biosimilars pipeline.
pharmaphorum
JUNE 19, 2024
Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.
Outsourcing Pharma
JUNE 19, 2024
Catching cancer early can save lives because it can be treated before it spreads in the body.
pharmaphorum
JUNE 19, 2024
Watch the exclusive interview with Henar Hevia and Carolyn Sousa at ASCO 2024 as they discuss the latest advancements in cancer research and treatment. Get insights and updates in this informative video.
Pharmaceutical Business Review
JUNE 19, 2024
New investors Mubadala Capital and Exor Ventures spearheaded this oversubscribed round. The Series B extension also saw participation from Qatar Investment Authority, alongside current stakeholders including Abingworth and Illumina Ventures. The additional funds add to the previously secured funds of $100m in the initial Series B round in October. Ascenta Capital and Abingworth jointly led the Series B funding round with contributions from NVIDIA and other investors.
Pharmafile
JUNE 19, 2024
Sobi has announced that the European Commission (EC) has granted marketing authorisation for Altuvoct (efanesoctocog alfa) for the treatment and prevention of bleeds and perioperative prophylaxis in haemophilia A. The post EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment appeared first on Pharmafile.
Pharmaceutical Commerce
JUNE 19, 2024
The latest news for pharma industry insiders.
pharmaphorum
JUNE 19, 2024
Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients
Pharmacy Joe
JUNE 19, 2024
In this episode, I’ll discuss recent articles regarding stress ulcer prophylaxis. Subscribe on iTunes , Android , or Stitcher The use of acid-suppressing agents to prevent the development of stress ulcers has been an area of intense research as the exact benefits and harms of this strategy in the context of modern ICU care is uncertain. Several articles have recently been published in New England Journal of Medicine to provide clarity on this topic.
Expert insights. Personalized for you.
351 
Let's personalize your content